[Form 4] NEOGEN CORP Insider Trading Activity

Rhea-AI Filing Summary

Catherine E. Woteki, a director of NEOGEN CORP (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of common stock on 10/07/2025. The RSUs were settled at a reported per-share value of $5.63, and following the transaction the reporting person beneficially owned 15,315 shares.

The filing is a routine Section 16 Form 4 reporting the vesting and settlement of equity compensation; it shows an increase in the director’s direct holdings but does not disclose any cash sale or purchase beyond the RSU settlement.

Positive

• 2,071 RSUs vested and were settled, converting compensation into direct equity
• Beneficial ownership increased to 15,315 shares, strengthening director alignment with shareholders

Negative

• None.

Insights

Corporate Governance Analyst

Director equity compensation vested into 2,071 shares on 10/07/2025.

The vesting and settlement of restricted stock units converts once‑subject-to‑restrictions equity into immediately owned common stock, increasing the director's direct holdings to 15,315 shares. This is a routine compensation event that aligns the director's economic interest with shareholders.

The main dependencies are timing of vesting schedules and any post‑vesting sales not reported here; investors can watch for subsequent Form 4 filings if shares are later sold within the short term.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Woteki Catherine E

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/07/2025		M		2,071	A	$5.63	15,315	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$5.63	10/07/2025		M			2,071	10/07/2025	10/07/2025	Common Stock	2,071	$5.63	0	D

Explanation of Responses:

Remarks:

Each RSU is the economic equivalent of one share of common stock. On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock.

	Christopher Sefcheck (Attorney in Fact)	10/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NEOG director Catherine Woteki report on Form 4 (NEOG)?

The Form 4 reports that 2,071 restricted stock units vested and were settled into 2,071 shares on 10/07/2025, bringing her beneficial ownership to 15,315 shares.

At what price were the RSUs settled for NEOG (NEOG)?

The filing lists a settlement value of $5.63 per share for the vested RSUs.

Does this Form 4 show a sale of NEOG shares by the director?

No. The filing shows RSUs vested and were settled for shares (acquisition), with no sale or disposition reported for those shares on 10/07/2025.

Who filed the Form 4 for NEOG (NEOG) on behalf of the reporting person?

The signature block shows Christopher Sefcheck (Attorney in Fact) signed the Form 4 on 10/09/2025 on behalf of the reporting person.

How can investors monitor further insider activity for NEOG (NEOG)?

Investors should watch for subsequent Section 16 filings (Form 4) which would report any sales or additional acquisitions after the 10/07/2025 vesting event.